Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.15Price to Sales
VS
Market
Sector
Industry
History
$ 6.25Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information
Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUCELL CORP - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ICCC - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 60.79M | 2.15 | $ 28.27M |
| 3/31/2025 | $ 44.37M | 1.63 | $ 27.3M |
| 12/31/2024 | $ 45M | 1.7 | $ 26.49M |
| 9/30/2024 | $ 31.46M | 1.32 | $ 23.84M |
| 6/30/2024 | $ 29.45M | 1.27 | $ 23.22M |
| 3/31/2024 | $ 42.78M | 2.01 | $ 21.28M |
| 12/31/2023 | $ 40.38M | 2.31 | $ 17.47M |
| 9/30/2023 | $ 40.3M | 2.47 | $ 16.29M |
| 6/30/2023 | $ 38.89M | 2.48 | $ 15.69M |
| 3/31/2023 | $ 38.42M | 2.4 | $ 16.01M |
Key Performance Insights, Last 5 Years
- IMMUCELL CORP's latest trailing twelve months (TTM) P/S stands at 2.69.
- Over the past 5 years, IMMUCELL CORP's average P/S has been 2.74.
- The median P/S for IMMUCELL CORP during this period was 2.44
- IMMUCELL CORP reached its highest P/S over the past 5 years at 4.9.
- The lowest P/S recorded by IMMUCELL CORP in the same timeframe 1.27
IMMUCELL CORP's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for IMMUCELL CORP is calculated as follows: Market Cap [ $ 40.97M ] / Revenues [ $ 15.23M ]
(=) P/S [ 2.69 ] ICCC - Price to Sales, Last 5 years
1.27
Minimum
Jun 30, 2024
4.9
Maximum
Mar 31, 2021
2.74
Average
2.44
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |